BACH1 517C→T transition impairs protein translocation to nucleus: A role in breast cancer susceptibility?

International Journal of Cancer

Volumn 104, Issue 3, 2003, Pages 389-391

  Lei, Haixin ^a,b   Vorechovsky, Igor ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; NUCLEAR PROTEIN; PROTEIN BACH1; UNCLASSIFIED DRUG; BACH1 PROTEIN, HUMAN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; FANCONI ANEMIA PROTEIN; GREEN FLUORESCENT PROTEIN; LEUCINE ZIPPER PROTEIN; PHOTOPROTEIN; TRANSCRIPTION FACTOR;

ALLELE; AMINO ACID SUBSTITUTION; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; GENE FREQUENCY; GENE MUTATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LETTER; ONCOGENE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RISK ASSESSMENT; SITE DIRECTED MUTAGENESIS; ALTERNATIVE RNA SPLICING; BREAST TUMOR; CELL NUCLEUS; CYTOPLASM; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; PLASMID;

ALTERNATIVE SPLICING; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BREAST NEOPLASMS; CELL NUCLEUS; CYTOPLASM; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GREEN FLUORESCENT PROTEINS; HUMANS; LEUCINE ZIPPERS; LUMINESCENT PROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PLASMIDS; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0037430741     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10947     Document Type: Letter

References (15)

1. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nature Genet 2002;31:33-6.
2. Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjakoski K, Pyrhonen S, Kallioniemi OP, Muhonen T, Luce M, et al. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 1997;6:2309-15.
3. Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Nad Acad Sci USA 2002;99:827-31.
4. Furuichi Y. Premature aging and predisposition to cancers caused by mutations in RecQ family helicases. Ann NY Acad Sci 2001;928:121-31.
5. Mohaghegh P, Hickson ID. DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders. Hum Mol Genet 2001;10:741-6.
6. van Brabant AJ, Stan R, Ellis NA. DNA helicases, genomic instability, and human genetic disease. Annu Rev Genomics Hum Genet 2000;1:409-59.
7. Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev 2001;15:15-23.
8. Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 2001;105:149-60.
9. Menichini P, Linial M. SUVi and BACH1: a new subfamily of mammalian helicases? Mutat Res 2001;487:67-71.
10. Luo L, Lei H, Du Q, von Wachenfeldt A, Kockum I, Luthman H, Vorechovsky I, Lindblom A. No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22. Int J Cancer 2002;98:638-9.
11. Jans DA, Chan CK, Huebner S. Signals mediating nuclear targeting and their regulation: application in drug delivery. Med Res Rev 1998;18:189 -223.
12. Shie JL, Tseng CC. A nucleus-localization-deficient mutant serves as a dominant-negative inhibitor of gut-enriched Kruppel-like factor function. Biochem Biophys Res Commun 2001;283:205-8.
13. Hayakawa S, Kaneko H, Fukao T, Kasahara K, Matsumoto T, Furuichi Y, Kondo N. Characterization of the nuclear localization signal in the DNA helicase responsible for Bloom syndrome. Int J Mol Med 2000;5:477-84.
14. Vorechovsky I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarstrom L, Webster AD, Yuille MA. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature Genet 1997;17:96-9.
15. Lei H, Sjoberg-Margolin S, Salahshor S, Werelius B, Jandakova E, Hemminki K, Lindblom A, Vorechovsky I. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 2002;98:199-204.